Cynthia de Luise

TL;DR: Patients with more severe COPD, as defined by the model, had higher cardiovascular morbidity and mortality than patients with less severe COPd.

TL;DR: In this cohort, persons with COPD have a 60–70% higher risk of death following hip fracture than those without COPD, and hip fracture and COPD increased 1-year mortality 3–5 times that of persons without hip fracture.

TL;DR: Hip fracture increased 1-year mortality more than 3-fold compared with mortality without hip fracture, and the presence of selected comorbidities further increased the risk of mortality after hip fracture among hip fracture subjects.

TL;DR: Compared to periods of non-use, tiotropium was associated with reduced respiratory and overall mortality and was not associated with increased cardiac mortality.

TL;DR: The results of this study indicate that ergot dopamine agonist use in Parkinson's disease patients was not associated with an increased risk of newly diagnosed heart failure, and among non-ergot dopamine agonists, there was a statistically significant association between pramipexole use and heart Failure, especially during the first months of therapy and in very old patients.